{
    "text": "Combining CDK4/6 inhibition with taxanes enhances anti-tumor efficacy by sustained impairment of pRB-E2F pathways in squamous cell lung cancer.", 
    "denotations": [
        {
            "id": "T1", 
            "obj": "CDK4/6", 
            "span": {
                "begin": 10, 
                "end": 16
            }
        }, 
        {
            "id": "T1", 
            "obj": "squamous cell lung cancer", 
            "span": {
                "begin": 117, 
                "end": 142
            }
        }
    ],
    "relations": [
        {
            "id":"R1",
            "pred":"causes",
            "subj":"T2", 
          "obj":"T1"}
    ]
}